Jasper Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.05

-0.06 (-5.41%)

As of Mar 29, 10:51 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 79%

Hold 3 21%

Sell 0 0%

Price Target

Analyst Price Target +3,758.1% upside

Low Target $28.40

Average Target $40.51

High Target $50.89

Current Price $1.05

Current
$1.05

Target
$40.51

$28.40 $40.51 avg $50.89

Scenario Analysis

Bear Case

$28.40

2,604.8%

Low target

Base Case

$40.51

+3,758.1%

Avg target

Bull Case

$50.89

+4,746.7%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$7.19

-85.4% from high

52-Week Low

$1.07

+-1.9% from low

Target vs 52W High

$40.51

+463.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%